Mary Kay Fenton - Chief Financial Officer at Tourmaline Bio, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
TRML
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mary Kay Fenton since 13 Mar 2025

Holdings reported by Mary Kay Fenton for Tourmaline Bio, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 68,054 $1,156,237 $16.99 03 Jul 2023 Direct

Transactions reported by Mary Kay Fenton for Tourmaline Bio, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.